Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps

Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps

Abstract Background Patients treated for cancer with immune checkpoint inhibitors (ICI) may develop autoimmune adverse events, including ICI-induced inflammatory arthritis (IA). ICI-induced IA treatment requires balancing immune activation to fight cancer and immune modulation to control autoimmunit...

Full description

Bibliographic Details
Main Authors: Laura C. Cappelli, Suzanne M. Grieb, Ami A. Shah, Clifton O. Bingham, Ana-Maria Orbai
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Rheumatology
Subjects:
Immunotherapy
Cancer
Inflammatory arthritis
Quality of life
Social support
Online Access:http://link.springer.com/article/10.1186/s41927-020-00133-8

Internet

http://link.springer.com/article/10.1186/s41927-020-00133-8

Similar Items